E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers N > Headlines for NovaBay Pharmaceuticals, Inc. > News item
Published on 12/5/2012 in the Prospect News PIPE Daily.

NovaBay Pharmaceuticals to price public offering of shares by Thursday

Company selects Lazard Capital Markets as its bookrunning manager

By Devika Patel

Knoxville, Tenn., Dec. 5 - NovaBay Pharmaceuticals, Inc. said it will price a public offering of common stock and warrants with a 30-day greenshoe by Thursday.

Lazard Capital Markets LLC is the bookrunning manager.

NovaBay Pharmaceuticals is a biotechnology company focused on addressing therapeutic needs of the anti-infective market.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.